Skin and kidney are commonly affected in systemic lupus erythematosus (SLE) with similar molecular mechanisms. Although clinical indicators of renal injury in SLE are fairly -uncontroversial, few biomarkers are reliable. The role of micro-RNAs (mi-RNAs) in lupus nephritis (LN) pathogenesis has been investigated to help in early diagnosis. The aim of work is to evaluate miRNA132 and SOX2 expressions in SLE Egyptian patients; with and without nephritis, and the relation between miRNA132 and its long non-coding gene SOX2 in both patients groups. This is a case-control study involving 100 SLE patients with and without LN (LN and non-LN groups), and 50 age-and sex-matched healthy controls. The study was carried out to detect miRNA132 and SOX2 expression by quantitative Real-Time Polymerase chain reaction methods. The SLE disease activity index (SLEDAI) was assessed. Our results showed that SLEDAI increased in LN compared to non-LN. Micro-RNA132 expression was significantly increased in patient groups compared to control and increased in LN more than non-LN group.SOX2 significantly decreased in patient groups compared to controls, and decreased more in LN compared to non-LN group. There was a negative correlation betweenmiRNA132 and SOX2 expression in both patients groups. In conclusion, miRNA132 and SOX2 may play a role in SLE activity and help in the early non-invasive diagnosis of LN.